Summary of malaria status and factors related to the introduction of radical cure for P . vivax malaria by country Factors related to malaria Thailand Cambodia
暂无分享,去创建一个
C. Wongsrichanalai | K. Thimasarn | R. Huy | Dysoley Lek | Suravadee Kitchakarn | N. Chinanonwait | A. Saejeng | Sea Thol | C. Hok
[1] S. Siv,et al. Plasmodium vivax Malaria in Cambodia , 2016, The American journal of tropical medicine and hygiene.
[2] J. Conn,et al. Epidemiology of Plasmodium vivax Malaria in Peru , 2016, The American journal of tropical medicine and hygiene.
[3] N. White,et al. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia , 2016, BMC Medicine.
[4] B. Ley,et al. Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines , 2016, PloS one.
[5] I. Elyazar,et al. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia , 2016, PLoS neglected tropical diseases.
[6] R. Price,et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report , 2015, Malaria Journal.
[7] S. D. Fernando,et al. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria , 2015, The Cochrane database of systematic reviews.
[8] Suttiphan Kitcharoen,et al. Relationship among glucose-6-phosphate dehydrogenase (G-6-PD) activity, G-6-PD variants and reticulocytosis in neonates of northeast Thailand. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[9] N. Speybroeck,et al. Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir , 2015, Malaria Journal.
[10] Q. Bassat,et al. G6PD deficiency in Latin America: systematic review on prevalence and variants , 2014, Memorias do Instituto Oswaldo Cruz.
[11] Jung-Yeon Kim,et al. First Evaluation of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Vivax Malaria Endemic Regions in the Republic of Korea , 2014, PloS one.
[12] P. Mandal,et al. Mass primaquine preventive treatment for control of Plasmodium vivax malaria in the Democratic People’s Republic of Korea: a country success story , 2014, WHO South-East Asia journal of public health.
[13] P. Charoenkwan,et al. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand. , 2014, The Southeast Asian journal of tropical medicine and public health.
[14] Q. Cheng,et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests , 2013, Malaria Journal.
[15] Pannamas Maneekan,et al. Border Malaria Associated with Multidrug Resistance on Thailand-Myanmar and Thailand-Cambodia Borders: Transmission Dynamic, Vulnerability, and Surveillance , 2013, BioMed research international.
[16] Sinuon Muth,et al. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients , 2013, Malaria Journal.
[17] S. Krudsood,et al. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Status Should be Screened in All Vivax Malaria Patients in Thailand Where Severe G6PD Deficiency is Predominant , 2013 .
[18] C. Wongsrichanalai,et al. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. , 2013, The Southeast Asian journal of tropical medicine and public health.
[19] N. Jitthai. Migration and malaria. , 2013, The Southeast Asian journal of tropical medicine and public health.
[20] S. Hewitt,et al. Malaria situation in the Greater Mekong Subregion. , 2013, The Southeast Asian journal of tropical medicine and public health.
[21] S. Hewitt,et al. Malaria control in the Greater Mekong Subregion: an overview of the current response and its limitations. , 2013, The Southeast Asian journal of tropical medicine and public health.
[22] D. Ménard,et al. Efficacy of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010 , 2012, Antimicrobial Agents and Chemotherapy.
[23] Anand P. Patil,et al. G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map , 2012, PLoS medicine.
[24] B. Therrell,et al. Consolidating newborn screening efforts in the Asia Pacific region , 2012, Journal of Community Genetics.
[25] S. Meshnick,et al. Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment , 2011, PloS one.
[26] Organização Mundial de Saúde,et al. World malaria report 2011 , 2011 .
[27] O. Ainoon,et al. G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization. , 2010, The Southeast Asian journal of tropical medicine and public health.
[28] V. Preedy,et al. Global Fund to Fight AIDS, Tuberculosis and Malaria , 2010 .
[29] Organización Mundial de la Salud. Guidelines for the treatment of malaria , 2010 .
[30] A. Peters,et al. Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in Women , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[31] Malcolm R Masso,et al. WORLD HEALTH ORGANIZATION Regional Office for the Western Pacific , 2005 .
[32] C. Hentschel. The Medicines for Malaria Venture , 2002, Nature.
[33] I. Nuchprayoon,et al. Glucose‐6‐phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population , 2002, Human mutation.
[34] Cole Trapnell,et al. TECHNICAL BRIEF: , 2001 .